We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The European Union recently implemented the EU Clinical Trials Directive (CTD) to better protect clinical trial participants while streamlining the bureaucracy to make the EU more attractive for clinical research (CTA, Nov. 17). CTA continues its monthly profiles of individual EU member states, detailing where each country stands on implementing the EU directive, as well as the steps sponsors must take to conduct trials. This month, CTA covers Latvia, one of the three Baltic Republics that regained their independence from the former Soviet Union in 1991.